All Stories

  1. Measurement of carotid plaque burden
  2. Letter to the Editor From Spence: [Prevalence and Characteristics of Low-Renin Hypertension in a Primary Care Population]
  3. Homocysteine and Myocardial Injury
  4. Correspondence on: “Subclinical atherosclerosis: More data – More insights into prevention”
  5. Reducing Cardiovascular Risk: The Potential of Plant-Based Meat Alternatives and Egg Substitutes
  6. Poor Results with “Best Medical Therapy” in Patients with Asymptomatic Carotid Stenosis
  7. Vessel Wall Volume and Plaque Volume Should Replace Carotid Intima–Media Thickness
  8. Prior-knowledge Embedded U-Net based Fully Automatic Vessel Wall Volume Measurement of the Carotid Artery in 3D Ultrasound Image
  9. Carotid Plaque Burden Is a Stronger Predictor of Cardiovascular Risk Than IMT
  10. Vertebrobasilar ischemia: Some less recognized aspects
  11. Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences
  12. Homocysteine and Thrombophilia in Pulmonary Hypertension
  13. Cardiovascular effects of TMAO and other toxic metabolites of the intestinal microbiome
  14. Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
  15. In Memoriam: Jim Toole, MD: Ahead of His Time
  16. B vitamins for NASH: use methylcobalamin, not cyanocobalamin
  17. Problem in the Recent American Heart Association Guideline on Secondary Stroke Prevention: B Vitamins to Lower Homocysteine Do Prevent Stroke
  18. Identifying High-Risk Nonstenotic Carotid Artery Disease
  19. Management of Patients with Embolic Stroke of Unknown Source: Interpreting the Evidence in the Light of Clinical Judgement
  20. Efficacy of Lower Doses of Pioglitazone after Stroke or Transient Ischemic Attack In Patients with Insulin Resistance
  21. Fasting lipids are not a good way to assess the effects of diet on cardiovascular risk
  22. How to identify which patients should not have a systolic blood pressure target of <120 mmHg
  23. Deep Learning-Based Measurement of Total Plaque Area in B-Mode Ultrasound Images
  24. Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
  25. CONNed in Pregnancy
  26. Physiological Treatment of Hypertension in Black Patients: Time for Action
  27. Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease
  28. Triglyceride/High‐Density Lipoprotein Cholesterol Ratio: A Clue to Metabolic Syndrome, Insulin Resistance, and Severe Atherosclerosis
  29. Renovascular Hypertension
  30. Cardiovascular Harm From Egg Yolk and Meat: More Than Just Cholesterol and Saturated Fat
  31. It's time to stop the nonsense of withholding lipid lowering therapy on account of age
  32. Measurement of carotid plaque burden: A tool for predicting and preventing dementia?
  33. Stroke Prevention: Little-Known and Neglected Aspects
  34. Reducing the Risk of Stroke in Patients with Impaired Renal Function: Nutritional Issues
  35. Stroke Prevention in Older Adults
  36. A Voxel-Based Fully Convolution Network and Continuous Max-Flow for Carotid Vessel-Wall-Volume Segmentation From 3D Ultrasound Images
  37. IMT is not atherosclerosis
  38. China Stroke Statistics 2019: a wealth of opportunities for stroke prevention
  39. Recent advances in preventing recurrent stroke
  40. New Canadian guideline is wrong to say acetylsalicylic acid is only for patients with symptomatic vascular disease
  41. Achieving blood pressure control targets in hypertensive patients of rural China – a pilot randomized trial
  42. Risk from low blood pressure in frail older adults: diastolic pressure and pulse pressure are important
  43. Stroke Prevention
  44. Interaction of smoking, hyperhomocysteinemia and metabolic syndrome with carotid atherosclerosis: A cross sectional study in 972 non-diabetic patients
  45. Traffic‐Related Air Pollution and Carotid Plaque Burden in a Canadian City With Low‐Level Ambient Pollution
  46. Impaired Renal Function and Cerebrovascular Disease
  47. Triglyceride lowering drugs: not just icosapent ethyl
  48. Adding Insight to Injury!
  49. Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial
  50. Lower risk of stroke with a vegetarian diet
  51. Choosing the right therapy for a patient with asymptomatic carotid stenosis
  52. Patent foramen ovale in patients with atrial fibrillation
  53. Three-dimensional ultrasound evaluation of the effects of pomegranate therapy on carotid plaque texture using locality preserving projection
  54. Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke
  55. Rationale for screening selected patients for asymptomatic carotid artery stenosis
  56. Asymptomatic Carotid Stenosis: High Risk With Suboptimal Treatment
  57. Longitudinal assessment of carotid plaque texture in three-dimensional ultrasound images based on semi-supervised graph-based dimensionality reduction and feature selection
  58. Mechanisms of Stroke in COVID-19
  59. The need for clinical judgement in the application of evidence-based medicine
  60. Chili Pepper Consumption and Cardiovascular Mortality
  61. Resistant Hypertension
  62. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017
  63. Trimethylamine N-oxide: not just red meat—egg yolk and renal function are also important
  64. Carotid Intima–Media Thickness Versus Carotid Plaque Burden for Predicting Cardiovascular Risk
  65. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs
  66. Registration of amiloride in South Africa: Cutting the Gordian knot
  67. Statins for Primary Prevention of Cardiovascular Disease
  68. Deep learning‐based carotid media‐adventitia and lumen‐intima boundary segmentation from three‐dimensional ultrasound images
  69. Coronary calcium is not all we need: Carotid plaque burden measured by ultrasound is better
  70. Periprocedural events dominate outcomes of carotid stenting and endarterectomy
  71. Nutrition and Risk of Stroke
  72. The Importance of Blood Pressure Gradients in the Brain
  73. Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack
  74. Pioglitazone Therapy in Patients With Stroke and Prediabetes
  75. Blood Pressure Gradients in the Brain: Their Importance to Understanding Pathogenesis of Cerebral Small Vessel Disease
  76. Anticoagulation in patients with Embolic Stroke of Unknown Source
  77. Vitamin B12 deficiency and hyperhomocysteinaemia in outpatients with stroke or transient ischaemic attack: a cohort study at an academic medical centre
  78. Increased carotid plaque burden in patients with family medical history of premature cardiovascular events in the absence of classical risk factors
  79. Hypertension in Africa
  80. Decline in the Severity of Carotid Atherosclerosis and Associated Risk Factors From 2002 to 2014
  81. Harm With High Levels of Serum B12 in Elderly Persons
  82. Cardiovascular benefit of egg consumption is most unlikely
  83. Advances in Stroke Prevention
  84. Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden
  85. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
  86. Data on the gut and saliva microbiota from a cohort of atherosclerosis patients determined by 16S rRNA gene sequencing
  87. Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications
  88. Hypertension in Blacks
  89. Fractal dimension based carotid plaque characterization from three-dimensional ultrasound images
  90. Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function
  91. Stroke Prevention: Editorial to accompany June issue of SVN
  92. [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events
  93. Egg Consumption and Cardiovascular Risk
  94. Supplemental Vitamins and Minerals for CVD Prevention and Treatment
  95. Metabolic products of the intestinal microbiome and extremes of atherosclerosis
  96. Diastolic J curve, cuff artefact and low targets for SBP
  97. Problems with polypills
  98. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension
  99. B Vitamins for Stroke Prevention
  100. Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position
  101. Cardioembolic stroke: everything has changed
  102. Controlling resistant hypertension
  103. How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting
  104. Effect of wine on carotid atherosclerosis in type 2 diabetes: a 2-year randomized controlled trial
  105. Diet for stroke prevention
  106. Letter by Spence Regarding Article, “Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort”
  107. Homocysteine Lowering with B Vitamins for Stroke Prevention—A History
  108. Hypertension in US-born vs. foreign-born African-Americans
  109. Association of homocysteine and smoking with cerebral microemboli in patients with mechanical heart valves: a transcranial Doppler study
  110. Letter by Spence Regarding Article, “Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis”
  111. Systolic blood pressure targets, diastolic J curve and cuff artefact in blood pressure measurement: a note of caution
  112. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
  113. Smoking cessation and outcome after ischemic stroke or TIA
  114. B vitamins in stroke prevention: time to reconsider
  115. Sensitive three-dimensional ultrasound assessment of carotid atherosclerosis by weighted average of local vessel wall and plaque thickness change
  116. Motor recovery beginning 23 years after ischemic stroke
  117. Cuff Artifact, J Curve, and Application of Hypertension Guidelines in the Elderly
  118. Approaching Automated 3-Dimensional Measurement of Atherosclerotic Plaque Volume ∗
  119. Recent advances in preventing stroke recurrence
  120. Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease
  121. Nutrition in Stroke Prevention
  122. Resistant Atherosclerosis
  123. Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa
  124. Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention
  125. Asymptomatic carotid stenosis
  126. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
  127. [ 18 F]-NaF PET/CT Identifies Active Calcification in Carotid Plaque
  128. 3D Ultrasound for Imaging and Quantifying Carotid Ulcers
  129. Diastolic Hypotension and Myocardial Ischemia
  130. Transcranial Doppler monitoring for microemboli: a marker of a high-risk carotid plaque
  131. Carotid plaque burden is associated with higher levels of total homocysteine
  132. CADASIL accelerated by acute hypotension
  133. Hypertension in blacks
  134. High Frequency of Variants of Candidate Genes in Black Africans with Low Renin-Resistant Hypertension
  135. Effects of eplerenone on resistance to antihypertensive medication in patients with primary or secondary hyperaldosteronism
  136. Increased Coagulation With Aging: Importance of Homocysteine and Vitamin B12
  137. Henry J.M. Barnett
  138. Determinants of carotid plaque burden
  139. Folic acid supplementation and chronic kidney disease progression
  140. Re: ‘Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease: A Systematic Review and Meta-Analysis’
  141. Intestinal Microbiome and Atherosclerosis
  142. Statins probably do not cause cataracts
  143. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients
  144. Editorial: Time for Earlier and More Intensive Preventive Therapy
  145. Latest Skirmishes in the Long-Term Battle Between Carotid Endarterectomy and Stenting
  146. Cryptogenic Stroke
  147. Taking care of volunteers in a stroke trial: a new assisted-management strategy
  148. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
  149. Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale
  150. Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence
  151. Recent advances in pathogenesis, assessment, and treatment of atherosclerosis
  152. Transcranial Doppler Emboli Identifies Asymptomatic Carotid Patients at High Stroke Risk: Why This Technique Should be Used More Widely
  153. Strategies for improving blood pressure control in Africa
  154. Appropriate management of asymptomatic carotid stenosis
  155. Endarterectomy vs. stenting vs. medical therapy
  156. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
  157. Endarterectomy, Stenting, or Neither for Asymptomatic Carotid-Artery Stenosis
  158. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke
  159. Plaque Assessment in the Management of Patients with Asymptomatic Carotid Stenosis
  160. Three-Dimensional Ultrasound of Carotid Plaque
  161. Overcoming Challenges With Statin Therapy
  162. Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease
  163. Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification
  164. Hypertension and Stroke
  165. Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis
  166. Management of Patients with an Asymptomatic Carotid Stenosis—Medical Management, Endovascular Treatment, or Carotid Endarterectomy?
  167. Transcranial Doppler: Uses in Stroke Prevention
  168. Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine
  169. J Curve and Cuff Artefact, and Diagnostic Inertia in Resistant Hypertension
  170. Risk of Stroke at the Time of Carotid Occlusion
  171. Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee
  172. Carotid Ultrasound Phenotypes Are Biologically Distinct
  173. Letter by Spence Regarding Article, “Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke”
  174. Importance of sex and gender in atherosclerosis and cardiovascular disease
  175. 3D carotid reconstructions: imaging, pathology, algorithms and pipelines
  176. Blood Pressure Control in Canada: The View From a Stroke Prevention Clinic
  177. Dilemmas in Diagnosing and Managing Hypertension: Is White Coat Hypertension Benign?
  178. Management of Asymptomatic Carotid Stenosis
  179. Statins and Cataracts: Reverse Causality?
  180. Recent advances in atrial fibrillation and stroke
  181. Aspirin for Prevention of Cardiovascular Events in Older Japanese Patients
  182. Letter by Spence Regarding Article, "Differential Effect of B-Vitamin Therapy by Antiplatelet Use on Risk of Recurrent Vascular Events After Stroke"
  183. Measurement of Carotid Plaque Burden
  184. Management of resistant hypertension
  185. Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial
  186. Are some diets "mass murder"? Mediterranean diet is not to blame for increased carbohydrate intake
  187. Statins and Intracerebral Hemorrhage
  188. The 99mTc-DTPA Urinary Clearance Method May Be Preferable to the Plasma Disappearance Method for Assessing Glomerular Filtration Rate in Diabetic Nephropathy
  189. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial
  190. Risk of Vascular Disease in Premenopausal Women With Diabetes Mellitus
  191. Identifying Which Patients With Asymptomatic Carotid Stenosis Could Benefit From Intervention: Table.
  192. Recurrent Stroke and Patent Foramen Ovale
  193. Cryptogenic Stroke and Atrial Fibrillation
  194. Secular Trends in Ischemic Stroke Subtypes and Stroke Risk Factors
  195. Statins and Ischemic Stroke
  196. How far to lower blood pressure in the long term, after a stroke?
  197. Time course of atherosclerosis regression
  198. Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies
  199. Three-Dimensional Carotid Ultrasound Plaque Texture Predicts Vascular Events
  200. Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction
  201. Atrial Fibrillation in Patients with Cryptogenic Stroke
  202. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals
  203. Pulmonary Abnormalities and Carotid Atherosclerosis in Ex-Smokers without Airflow Limitation
  204. A Single Fixed-Dose Combination for All Patients Is Bad Medicine
  205. Volume of Carotid Artery Ulceration as a Predictor of Cardiovascular Events
  206. Microhabitat Use in a Northern Peripheral Population ofApodemia mormo: Factors Beyond the Host Plant
  207. Free fatty acids to predict recurrent ischemic stroke
  208. Effects of the Intestinal Microbiome on Constituents of Red Meat and Egg Yolks: A New Window Opens on Nutrition and Cardiovascular Disease
  209. SPARKLE (Subtypes of Ischaemic Stroke Classification System), Incorporating Measurement of Carotid Plaque Burden: A New Validated Tool for the Classification of Ischemic Stroke Subtypes
  210. Carotid Stenosis
  211. Egg consumption and coronary disease: Letter to the editor regarding Chagas P, Caramori P, Galdino TP, Barcellos CS, Gomes I, Schwanke CH. Egg consumption and coronary atherosclerotic burden. Atherosclerosis 2013 August;229(2):381–4
  212. Trust between specialists and family physicians
  213. One, two and three-dimensional ultrasound measurements of carotid atherosclerosis before and after cardiac rehabilitation: preliminary results of a randomized controlled trial
  214. Intensive risk factor control in stroke prevention
  215. Retinal Vasculature: A Window on the Brain
  216. Barometer in the Storm—Carotid Artery Plaque Quantified by Three-Dimensional Ultrasound
  217. Treatment of Renal Artery Stenosis
  218. Progression of Carotid Plaque Volume Predicts Cardiovascular Events
  219. Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
  220. Why Calls for More Routine Carotid Stenting Are Currently Inappropriate: An International, Multispecialty, Expert Review and Position Statement
  221. Egg yolk consumption, smoking and carotid plaque: Reply to letters to the Editor by Sean Lucan and T Dylan Olver et al.
  222. Atherosclerosis Imaging and the Canadian Atherosclerosis Imaging Network
  223. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals
  224. Migraine, Shear Stress, and Platelet Serotonin
  225. Diabetes, Intracranial Stenosis and Microemboli in Asymptomatic Carotid Stenosis
  226. Asymptomatic Carotid Stenosis
  227. Blood pressure and opera
  228. Ultrasonographic Measure of Carotid Plaque Burden
  229. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes
  230. Antihypertensive treatment can prevent stroke and cognitive decline
  231. Atrial fibrillation and stroke prevention: is warfarin still an option? Yes
  232. Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque
  233. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: What Leonardo da Vinci could not see
  234. Egg yolk consumption and carotid plaque
  235. Premature Atherosclerosis Is Associated With Hypovitaminosis D and Angiotensin-Converting Enzyme Inhibitor Non-use in Lupus Patients
  236. Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding
  237. Albuminuria and risk of stroke in African Americans: A marker of uncontrolled hypertension?
  238. Statins do not cause intracerebral hemorrhage
  239. Genetics of atherosclerosis: The power of plaque burden and progression
  240. Mechanisms of Lipoprotein(a) Pathogenicity: Prothrombotic, Proatherosclerotic, or Both?
  241. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
  242. Lessons From Africa: The Importance of Measuring Plasma Renin and Aldosterone in Resistant Hypertension
  243. Why the US Center for Medicare and Medicaid Services Should Not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  244. Pseudohypertension
  245. Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting
  246. Why the United States Center for Medicare and Medicaid Services (CMS) Should not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  247. Identifying high-risk asymptomatic carotid stenosis
  248. Why the United States Center for Medicare and Medicaid Services should not extend reimbursement indications for carotid artery angioplasty/stenting
  249. Ezetimibe and Regression of Carotid Atherosclerosis
  250. Carotid plaque measurement is superior to IMT
  251. Understanding the Complexity of Homocysteine Lowering With Vitamins
  252. High-risk asymptomatic carotid stenosis: Ulceration on 3D ultrasound vs TCD microemboli
  253. Short-acting nifedipine and risk of stroke
  254. New and Emerging Weight Management Strategies for Busy Ambulatory Settings: A Scientific Statement From the American Heart Association * Endorsed by the Society of Behavioral Medicine
  255. Asymptomatic Carotid Stenosis: Identifying Patients at High Enough Risk to Warrant Endarterectomy or Stenting
  256. Influence of Noninvasive Cardiovascular Imaging in Primary Prevention
  257. Reply to Letters from Dr Maria Luz Fernandez, Eddie Vos, and Dr Niva Shapira
  258. Toward Clinical Applications of Carotid Ultrasound: Intima-Media Thickness, Plaque Area, and Three-Dimensional Phenotypes
  259. Carotid Plaque Surface Irregularity
  260. Volumetric Evaluation of Carotid Atherosclerosis Using 3-Dimensional Ultrasonic Imaging
  261. Response to Letter by Hadjiev et al
  262. 3D Carotid Ultrasound Imaging
  263. Clinical Clues to Paradoxical Embolism
  264. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific MortalityMeta-analysis of 8 Randomized Trials Involving 37 485 IndividualsEffects of Lowering Homocysteine Lev...
  265. Is there a role for revascularisation in asymptomatic carotid stenosis? No
  266. Is there a role for revascularisation in asymptomatic carotid stenosis? Yes
  267. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
  268. B-Vitamin Therapy for Diabetic Nephropathy—Reply
  269. Secondary stroke prevention
  270. Identifying high-risk patients from carotid plaque composition
  271. Asymptomatic Carotid Stenosis: Mainly a Medical Condition
  272. Physiologic Tailoring of Treatment in Resistant Hypertension
  273. Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy
  274. Treating Arteries Instead of Risk Factors: A Paradigm Change in Management of Atherosclerosis
  275. Extremes of Unexplained Variation as a Phenotype: An Efficient Approach for Genome-Wide Association Studies of Cardiovascular Disease
  276. Three-dimensional ultrasound-based texture analysis of the effect of atorvastatin on carotid atherosclerosis
  277. Dietary Intervention to Reverse Carotid Atherosclerosis
  278. The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions
  279. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics
  280. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in Asymptomatic Carotid Stenosis
  281. Three-Dimensional Carotid Ultrasound Segmentation Variability Dependence on Signal Difference and Boundary Orientation
  282. Three-dimensional Ultrasound Quantification of Intensive Statin Treatment of Carotid Atherosclerosis
  283. Treating Hypertension in Acute Ischemic Stroke
  284. Atrial fibrillation, stroke prevention therapy and aging
  285. Longitudinal Ultrasound Evaluation of Carotid Atherosclerosis in One, Two and Three Dimensions
  286. Mechanisms of thrombogenesis in atrial fibrillation
  287. Analysis of carotid lumen surface morphology using three-dimensional ultrasound imaging
  288. Nonrigid registration of three-dimensional ultrasound and magnetic resonance images of the carotid arteries
  289. Carotid Atherosclerosis and a Reduced Likelihood for Lowered Cognitive Performance in a Canadian First Nations Population
  290. Diagnosis of primary aldosteronism: for medical management, not just surgery
  291. Mesna for the Treatment of Hyperhomocysteinemia in Hemodialysis Patients
  292. Area-preserving flattening maps of 3D ultrasound carotid arteries images
  293. Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism
  294. Scan–rescan and intra-observer variability of magnetic resonance imaging of carotid atherosclerosis at 1.5 T and 3.0 T
  295. Is Carotid Intima-Media Thickness a Reliable Clinical Predictor?
  296. A “Twisting and Bending” Model-Based Nonrigid Image Registration Technique for 3-D Ultrasound Carotid Images
  297. Angiotensin inhibition in renovascular disease: A population-based cohort study
  298. The importance of distinguishing between diffuse carotid intima-media thickening and focal plaque
  299. Quantification of carotid vessel wall and plaque thickness change using 3D ultrasound images
  300. Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
  301. Geometry of the Carotid Bifurcation Predicts Its Exposure to Disturbed Flow
  302. Intra-Arterial Thrombolysis of Occluded Middle Cerebral Artery by Use of Collateral Pathways in Patients with Tandem Cervical Carotid Artery/Middle Cerebral Artery Occlusion
  303. Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome
  304. Polypill: For Pollyanna*
  305. Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
  306. White-Coat Hypertension Is Hypertension
  307. Nonrigid registration of carotid ultrasound and MR images using a "twisting and bending" model
  308. APPENDIX A: Carotid Endarterectomy-An Evidence-Based Review
  309. Mapping Spatial and Temporal Changes in Carotid Atherosclerosis from Three-Dimensional Ultrasound Images
  310. Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension
  311. Homocysteine-lowering therapy: a role in stroke prevention?
  312. Letter by Rundek et al Regarding Article, "Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis"
  313. Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
  314. Stroke prevention in the high-risk patient
  315. Plasma total homocysteine in acute stroke
  316. SU-EE-A4-01: Development of Cardiac-Gated 3-Dimensional Ultrasound Imaging of Carotid Atherosclerosis
  317. Validation of 3D Ultrasound Vessel Wall Volume: An Imaging Phenotype of Carotid Atherosclerosis
  318. New treatment options for hypertension during acute ischemic or hemorrhagic stroke
  319. Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
  320. Manual planimetric measurement of carotid plaque volume using three-dimensional ultrasound imaging
  321. Effects of non-steroidal anti-inflammatory drugs on blood pressure
  322. Hypertension Due to Central Nervous System Dysfunction
  323. Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions
  324. Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial
  325. The Effect of Mesna on Plasma Total Homocysteine Concentration in Hemodialysis Patients
  326. 3D ultrasound analysis of carotid plaque volume and surface morphology
  327. Carotid ultrasound phenotypes in vulnerable populations
  328. Homocysteine and Stroke Prevention: Have the Trials Settled the Issue?
  329. Measurement of Intima-Media Thickness vs. Carotid Plaque: Uses in Patient Care, Genetic Research and Evaluation of New Therapies
  330. Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research and therapy evaluation
  331. A Non-Rigid Image Registration Technique for 3D Ultrasound Carotid Images using a "Twisting and Bending" Model
  332. Measuring Effects of Antiatherosclerotic Therapies
  333. Quantification of progression and regression of carotid vessel atherosclerosis using 3D ultrasound images
  334. Thiol exchange: An in vitro assay that predicts the efficacy of novel homocysteine lowering therapies
  335. Nutrition and Stroke Prevention
  336. Relationship of the metabolic syndrome to carotid ultrasound traits
  337. Po-Thur Eve General-20: A Novel Non-Invasive 3D Ultrasound Imaging Phenotype of Carotid Atherosclerosis
  338. Po-Thur Eve General-24: Non-Invasive Imaging Phenotypes of Carotid Atherosclerosis in Subjects: MRI, B-mode and 3D Ultrasound Measurements
  339. Treating Hypertension in Acute Stroke: A Better Arrow for the Quiver
  340. Lipoprotein(a): Involved in Events, but Not Burden of Atherosclerotic Disease?
  341. Folate supplementation and cardiovascular disease
  342. Quantification of carotid vessel atherosclerosis
  343. Letter to the Editor: Individualized Therapy for Hypertension
  344. Homocysteine: Call Off the Funeral
  345. 3D Ultrasound System for Analysis of Carotid Plaque Progression and Regression
  346. Tutorial in Biostatistics: Analyzing Associations between Total Plasma Homocysteine and B Vitamins Using Optimal Categorization and Segmented Regression
  347. Disparate Associations of a Functional Promoter Polymorphism in PCK1 With Carotid Wall Ultrasound Traits
  348. Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
  349. Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis
  350. Variation in the Carotid Bifurcation Geometry of Young Versus Older Adults: Implications for Geometric Risk of Atherosclerosis
  351. Erratum to “Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions” [Atherosclerosis 178(2) (2005) 319–325]
  352. Carotid endarterectomy--An evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
  353. 3D Ultrasound Measurement of Change in Carotid Plaque Volume: A Tool for Rapid Evaluation of New Therapies
  354. Complications of Type 2 Diabetes Among Aboriginal Canadians: Prevalence and associated risk factors
  355. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes
  356. Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products
  357. Quantification of carotid plaque volume measurements using 3D ultrasound imaging
  358. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions
  359. Anthropometric data for magnetic resonance imaging of the carotid bifurcation
  360. Carotid Ultrasound in One, Two and Three Dimensions
  361. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: A placebo-controlled, double-blind, randomized trial
  362. The current epidemic of primary aldosteronism
  363. Carotid intima-media thickness and cognitive decline: what does it mean for prevention of dementia?
  364. Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor   Associated With Carotid Atherosclerosis
  365. Non-Invasive Assessment of Atherosclerosis Risk
  366. 3D Ultrasound Imaging of the Carotid Arteries
  367. Preventing Dementia by Treating Hypertension and Preventing Stroke
  368. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration
  369. Measurement of Carotid Plaque Volume by 3-Dimensional Ultrasound
  370. Noninvasive Phenotypes of Atherosclerosis: Similar Windows but Different Views
  371. Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
  372. Sex Differences in Carotid Plaque and Stenosis
  373. The Effect of Flax Seed Cultivars with Differing Content of α-Linolenic Acid and Lignans on Responses to Mental Stress
  374. Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease
  375. Lipoprotein Lipase (LPL) Gene Variation and Progression of Carotid Artery Plaque
  376. Infection, Inflammation, and Atherosclerosis
  377. Measurement of Carotid Plaque and Effect of Vitamin Therapy for Total Homocysteine
  378. Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy
  379. Treatment options for renovascular hypertension
  380. Grapefruit juice-drug interactions
  381. Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI
  382. Knowledge gaps
  383. Actual practice in hypertension: Implications for persistence with and effectiveness of therapy
  384. Endarterectomy or angioplasty for treatment of carotid stenosis?
  385. Homocyst(e)ine, nitrous oxide and atherosclerosis
  386. Improved Outcomes in Stroke Thrombolysis with Pre-specified Imaging Criteria
  387. Patients With Atherosclerotic Vascular Disease
  388. Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design
  389. Effect of amlodipine on hemodynamic and endocrine responses to mental stress
  390. Angiotensin II antagonists for hypertension: are there differences in efficacy?
  391. Hypocholesterolemic effects of dietary citrus juices in rabbits
  392. Management of Resistant Hypertension in Patients with Carotid Stenosis: High Prevalence of Renovascular Hypertension
  393. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L
  394. Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
  395. Contents of Related Journals
  396. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema
  397. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis
  398. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial
  399. Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily
  400. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis
  401. Editorial commentary
  402. Carotid Endarterectomy Does Not Affect Long-Term Blood Pressure: Observations from the NASCET
  403. Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
  404. Metabolism of Fibric Acid Derivatives
  405. Informing the public
  406. Pseudo-hypertension in the elderly: still hazy, after all these years
  407. Correspondence
  408. Grapefruit juice—terfenadine single-dose interaction: Magnitude, mechanism, and relevance*
  409. Psychological stress and the progression of carotid artery disease
  410. Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice*
  411. The acetylcholinesterase oxime reactivator HI-6 in man: Pharmacokinetics and tolerability in combination with atropine
  412. Government guidelines for treatment of hypertension
  413. Prognosis for Patients Following a Transient Ischemic Attack With and Without a Cerebral Infarction on Brain CT
  414. Grapefruit Juice and Drugs
  415. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics
  416. Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin
  417. Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?
  418. Tests for renal vascular disease
  419. Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
  420. Interaction of citrus juices with felodipine and nifedipine
  421. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning
  422. Measurement of Atherosclerosis: Development of an Atherosclerosis Severity Index
  423. EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICS
  424. Evaluation of once daily endralazine in hypertension
  425. The arthritic patient with hypertension: Selection of an NSAID
  426. Hypertension in Acute Ischemic Strokes
  427. EFFECTS OF TRIAMTERENE AND AMILORIDE ON URINARY SEDIMENT IN HYPERTENSIVE PATIENTS TAKING HYDROCHLOROTHIAZIDE
  428. Blood Pressure Measurement in the Elderly: Correlation of Arterial Stiffness with Difference Between Intra-arterial and Cuff Pressures
  429. Spectrum of benign intracranial hypertension in children and adolescents
  430. Hemodynamic modification of aortic atherosclerosis
  431. Potassium-sparing Diuretics: Interaction with Digoxin in Elderly Men
  432. Phenytoin-Theophylline Interaction
  433. Pseudohypertension in the Elderly
  434. Vitamins and antioxidants